AUTOIMMUNE TECHNOLOGIES, LLC

Address

AUTOIMMUNE TECHNOLOGIES, LLC
1010 Common Street, Suite 1705
NEW ORLEANS, LA, -

Information

DUNS: 946839156
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Peptide inhibitors of coronavirus entry

    Amount: $225,000.00

    DESCRIPTION (provided by applicant): The broad long-term objectives of the proposed work are to develop effective medical countermeasures to be used for the treatment of viral infectious disease cause ...

    SBIRPhase I2014Department of Health and Human Services
  2. Peptide inhbitors of influenza entry-FAST TRACK

    Amount: $2,633,980.00

    DESCRIPTION (provided by applicant): Between 10% and 20% of the United State population suffer from seasonal influenza each year. While most individuals recover from influenza in one to two weeks, the ...

    SBIRPhase II2010Department of Health and Human Services
  3. Peptide inhbitors of influenza entry-FAST TRACK

    Amount: $1,304,710.00

    DESCRIPTION (provided by applicant): Between 10% and 20% of the United State population suffer from seasonal influenza each year. While most individuals recover from influenza in one to two weeks, the ...

    SBIRPhase I2009Department of Health and Human Services
  4. Peptide drugs against influenza virus

    Amount: $922,901.00

    DESCRIPTION (provided by applicant): Influenza virus is one of the most important human pathogens accounting for widespread morbidity and mortality. Influenza virus is currently classified as a NIAID ...

    STTRPhase I2006Department of Health and Human Services
  5. Development of molecular diagnostic assays for systemic autoimmune diseases

    Amount: $99,838.00

    DESCRIPTION (provided by applicant): We aim to produce a significantly improved diagnostic system for autoimmune, rheumatologic disease. Similarities between autoimmune diseases and HIV-induced diseas ...

    STTRPhase I2006Department of Health and Human Services
  6. DIAGNOSTIC TEST FOR CHRONIC FATIGUE AND FIBROMYALGIA

    Amount: $65,690.00

    The long-term goal is to demonstrate that the Anti-Polymer Antibody Assay is diagnostic for chronic fatigue syndrome patients and fibromyalgia patients. In a pilot study 55 % (6/11) of chronic fatigue ...

    SBIRPhase I1997Department of Health and Human Services
  7. Peptide drugs against influenza virus

    Amount: $922,901.00

    DESCRIPTION (provided by applicant): Influenza virus is one of the most important human pathogens accounting for widespread morbidity and mortality. Influenza virus is currently classified as a NIAID ...

    SBIRPhase IDepartment of Health and Human Services
  8. Development of molecular diagnostic assays for systemic autoimmune diseases

    Amount: $99,838.00

    DESCRIPTION (provided by applicant): We aim to produce a significantly improved diagnostic system for autoimmune, rheumatologic disease. Similarities between autoimmune diseases and HIV-induced diseas ...

    SBIRPhase IDepartment of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government